Restricted accessOtherFirst published online 2017-12
Evaluation and Characterization of Monoclonal Gammopathies Using Serum Protein Electrophoresis in A Major Urban Population: One Institution'S Experience
AttaelmannanM, LevinsonSS. Understanding and identifying monoclonal gammopathies. Clin Chem2000;46:1230–8.
2.
O'ConnellTX, HoritaTJ, KasraviB. Understanding and interpreting serum protein electrophoresis. Am Fam Physician2005;71:105–12.
3.
IwanagaM, TagawaM, TsukasakiK, . Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan. Mayo Clin Proc2007;82:1474–9.doi:10.1016/S0025-6196(11)61090-2
4.
KyleRA, TherneauTM, RajkumarSV, . Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med2006;354:1362–9.doi:10.1056/NEJMoa054494
5.
ParkHK, LeeKR, KimYJ, . Prevalence of monoclonal gammopathy of undetermined significance in an elderly urban Korean population. Am J Hematol2011;86:752–5.doi:10.1002/ajh.22095
6.
CohenHJ, CrawfordJ, RaoMK, . Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly. Am J Med1998;104:439–44.doi:10.1016/S0002-9343(98)00080-1
7.
BrownLM, GridleyG, CheckD, . Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood2008;111:3388–94.doi:10.1182/blood-2007-10-121285
8.
LandgrenO, GridleyG, TuressonI, . Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood2006;107:904–6.doi:10.1182/blood-2005-08-3449
9.
LandgrenO, WeissBM. Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis. Leukemia2009;23:1691–7.doi:10.1038/leu.2009.134
10.
LandgrenO, GraubardBI, KatzmannJA, . Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey. Leukemia2014;28:1537–42.doi:10.1038/leu.2014.34
